Thus, the hyperexpression of HIF-1α in GBM leads to the hyperexpression of FAT, FABPpm, FATP, and, secondarily, the increase in the absorption of FAs and the formation of LDs in the tumor microenvironment. The gene discussed is SLC27A1; the disease is glioblastoma.